Ranked #1 during August 2012: Bupropion versus methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder: randomized double-blind study.
Study design & execution: A 6 week, randomized, double blinded, parallel design. Elements of the trial design are clearly detailed (as per the CONSORT statement) in Methods section of the text.
The study's primary outcome variable remains consistent from the registry to the top-line result:
